{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Stool+and+Blood+Specimen+Collection&page=2", "query": { "intervention": "Stool and Blood Specimen Collection", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Stool+and+Blood+Specimen+Collection&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T21:45:50.588Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00477100", "title": "Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Inflammatory Breast Carcinoma", "Invasive Breast Carcinoma", "Second Primary Malignant Neoplasm" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Interview", "type": "OTHER" }, { "name": "Medical Chart Review", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2007-04-17", "completion_date": "2030-04-30", "has_results": false, "last_update_posted_date": "2026-04-15", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 10, "location_summary": "Gilbert, Arizona • La Jolla, California • Greeley, Colorado + 6 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Greeley", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Saginaw", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00477100" }, { "nct_id": "NCT05947500", "title": "Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8", "Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8", "Locally Advanced Merkel Cell Carcinoma", "Metastatic Merkel Cell Carcinoma", "Refractory Merkel Cell Carcinoma", "Unresectable Merkel Cell Carcinoma" ], "interventions": [ { "name": "Avelumab", "type": "DRUG" }, { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Tuvusertib", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2024-05-21", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 50, "location_summary": "Irvine, California • La Jolla, California • Los Angeles, California + 39 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05947500" }, { "nct_id": "NCT06606119", "title": "The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Trauma Injury", "Trauma", "Critical Illness", "Microbiome", "Chronic Anemia", "Acute Blood Loss Anemia" ], "interventions": [ { "name": "Data and tissue collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 275, "start_date": "2025-01-24", "completion_date": "2028-10-01", "has_results": false, "last_update_posted_date": "2026-02-06", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 3, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06606119" }, { "nct_id": "NCT03270085", "title": "Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Diarrhea", "Irritable Bowel Syndrome With Diarrhea", "Bile Acid Malabsorption" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2017-12-07", "completion_date": "2019-05-31", "has_results": true, "last_update_posted_date": "2020-04-27", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03270085" }, { "nct_id": "NCT06122896", "title": "Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Pancreatic Cancer", "Pancreatic Ductal Adenocarcinoma", "PDAC", "PDAC - Pancreatic Ductal Adenocarcinoma", "Pancreatic Neoplasm" ], "interventions": [ { "name": "Screening Blood Tests", "type": "OTHER" }, { "name": "Endoscopic Ultrasound", "type": "DIAGNOSTIC_TEST" }, { "name": "Magnetic Resonance Imaging", "type": "COMBINATION_PRODUCT" }, { "name": "Magnetic Resonance Cholangiopancreatography", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST", "COMBINATION_PRODUCT" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5000, "start_date": "2023-11-21", "completion_date": "2041-10-31", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06122896" }, { "nct_id": "NCT03557749", "title": "Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Immune and Microbial Reconstitution", "Systemic Viral Infection", "Acute-graft-versus-host Disease", "Chronic Graft-versus-host-disease", "Recurrent Malignancy", "Cytokine Release Syndrome", "Allogenic Related Donors", "Cell Therapy/Immunotherapy Patients" ], "interventions": [ { "name": "Blood Sample", "type": "DIAGNOSTIC_TEST" }, { "name": "Stool Sample", "type": "DIAGNOSTIC_TEST" }, { "name": "Urine Sample", "type": "DIAGNOSTIC_TEST" }, { "name": "Bronchoalveolar Lavage (BAL) fluid", "type": "DIAGNOSTIC_TEST" }, { "name": "Gastrointestinal biopsy x 2-4", "type": "DIAGNOSTIC_TEST" }, { "name": "Skin biopsy", "type": "DIAGNOSTIC_TEST" }, { "name": "Skin, mouth, and/or ocular swab", "type": "DIAGNOSTIC_TEST" }, { "name": "Apheresis Product", "type": "DIAGNOSTIC_TEST" }, { "name": "Final cellular product", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 210, "start_date": "2018-09-21", "completion_date": "2023-08-15", "has_results": false, "last_update_posted_date": "2023-08-21", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03557749" }, { "nct_id": "NCT07675967", "title": "Clonal Hematopoiesis Chemotherapy and Radiation Effects Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lung Cancer (Diagnosis)", "Osteochondroma", "Spitz Nevus", "Solid Cancers", "Breast Cancer", "Gastric (Stomach) Cancer", "Colorectal (Colon or Rectal) Cancer", "Sarcoma", "Ovarian Adenocarcinoma", "Uterine Adenocarcinoma", "Endometrial Adenocarcinoma", "Esophageal Adenocarcinoma", "Head and Neck Cancer", "Therapy-Related Acute Myeloid Leukemia", "Therapy-Related MDS", "Clonal Hematopoiesis of Indeterminate Potential (CHIP)", "Clonal Cytopenia of Undetermined Significance" ], "interventions": [ { "name": "Samples", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5000, "start_date": "2025-04-04", "completion_date": "2035-03-31", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07675967" }, { "nct_id": "NCT05610527", "title": "Hormonal Influences on Inflammatory Bowel Diseases", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Inflammatory Bowel Diseases", "Contraception", "Menstrual Problem" ], "interventions": [ { "name": "Proposed study design and randomization scenarios", "type": "OTHER" }, { "name": "Repeated measures of validated Inflammatory Bowel Disease Patient Reported Outcome Instruments", "type": "OTHER" }, { "name": "Inflammatory marker collection and assessment for correlation with PRO responses and menstrual timing", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 50, "start_date": "2025-07-01", "completion_date": "2025-12-09", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05610527" }, { "nct_id": "NCT04063501", "title": "Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "Bronchoscopy", "type": "OTHER" }, { "name": "Research Procedures", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 48, "start_date": "2021-02-09", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2025-12-02", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04063501" }, { "nct_id": "NCT03513952", "title": "Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Bladder Urothelial Carcinoma", "Advanced Ureter Urothelial Carcinoma", "Metastatic Bladder Urothelial Carcinoma", "Metastatic Renal Pelvis Urothelial Carcinoma", "Metastatic Ureter Urothelial Carcinoma", "Metastatic Urethral Urothelial Carcinoma", "Metastatic Urothelial Carcinoma", "Recurrent Bladder Urothelial Carcinoma", "Recurrent Renal Pelvis Urothelial Carcinoma", "Recurrent Ureter Urothelial Carcinoma", "Recurrent Urethral Urothelial Carcinoma", "Stage III Bladder Cancer AJCC v8", "Stage III Renal Pelvis Cancer AJCC v8", "Stage III Ureter Cancer AJCC v8", "Stage III Urethral Cancer AJCC v8", "Stage IV Bladder Cancer AJCC v8", "Stage IV Renal Pelvis Cancer AJCC v8", "Stage IV Ureter Cancer AJCC v8", "Stage IV Urethral Cancer AJCC v8", "Stage IVA Bladder Cancer AJCC v8", "Stage IVB Bladder Cancer AJCC v8", "Unresectable Bladder Urothelial Carcinoma", "Unresectable Renal Pelvis Urothelial Carcinoma", "Unresectable Ureter Urothelial Carcinoma" ], "interventions": [ { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Glycosylated Recombinant Human Interleukin-7", "type": "BIOLOGICAL" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography and Computed Tomography Scan", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2019-06-05", "completion_date": "2024-04-01", "has_results": true, "last_update_posted_date": "2024-07-26", "last_synced_at": "2026-09-27T21:45:50.588Z", "location_count": 9, "location_summary": "Riverside, California • Tampa, Florida • Honolulu, Hawaii + 5 more", "locations": [ { "city": "Riverside", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03513952" } ] }